ALDA Pharmaceuticals Corporation Expands Agreement for China

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - May 31, 2007) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) (the “Company”) is pleased to announce that a new, expanded license has been granted for manufacturing, marketing and distribution of ALDA’s T36® products in China. At ALDA’s request, distribution of products manufactured in China to other countries is allowed under this license.

MORE ON THIS TOPIC